New Imaging Methods of Coronary Arteries in Acute Coronary Syndromes

1. Huang D, Swanson EA, Lin CP, et al. Optical coherent tomography. Science. 1991;254:1178-1181.10.1126/science.195716946381691957169Search in Google Scholar

2. Prati F, Regar E, Mintz GS, et al. Imaging of atherosclerosis: optical coherence tomography (OCT). Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. Eur Heart J 2010; 31:401-415.10.1093/eurheartj/ehp43319892716Search in Google Scholar

3. Špaček R, Červinka P. Nové možnosti zobrazení koronárních tepen - optická koherentní tomografie. Cor Vasa. 2009;Supplementum 1:43-46.10.33678/cor.2009.221Search in Google Scholar

4. Regar E, Ligthart J, Bruining N, van Soest G. The diagnostic value of intracoronary optical coherence tomography. Herz. 2011;36:417-429.10.1007/s00059-011-3487-721744151Search in Google Scholar

5. Hong MK, Mintz GS, Lee CW et al. Late stent malaposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation. 2006;113:414-419.10.1161/CIRCULATIONAHA.105.56340316432073Search in Google Scholar

6. Tanigawa J, Barlis P, Kaplan S, Goktekin OCD. Stent strup apposition in complex lesions using optical coherence tomography. Am J Cardiol. 2006;98(Suppl 1):97M.Search in Google Scholar

7. Radu M, Jørgensen E, Kelbæk H, Helqvist S, Skovgaard L, Saunamäki K. Optical coherence tomography at followup after percutaneous coronary intervention: relationship between procedural dissections, stent strut malapposition and stent healing. EuroIntervention. 2011;7:353-361.10.4244/EIJV7I3A6021729838Search in Google Scholar

8. Reimers B, Nikas D, Stabile E, Favero L, Saccà S, Cremonesi A, Rubino P. Preliminary experience with optical coherence tomography imaging to evaluate carotid artery stents: safety, feasibility and techniques. EuroIntervention. 2011;7:98-105.10.4244/EIJV7I1A1721550909Search in Google Scholar

9. Liu Y, Imanishi T, Kubo T, et al. Assessment by optical coherence tomography of stent struts across side branch. Comparison of bare-metal stents and drug-elution stents. Circ J. 2010;75:106-112.10.1253/circj.CJ-10-0574Search in Google Scholar

10. Murata A, Wallace-Bradley D, Tellez A, et al. Accuracy of optical coherent tomography in the evaluation of neointimal coverage after stent implantation. JACC Cardiovasc Imaging. 2010;3:76-84.10.1016/j.jcmg.2009.09.01820129535Search in Google Scholar

11. Suzuki Y, Ikeno F, Koizumi T, et al. In vivo comparison between optical coherent tomography and intravascular ultrasound for detecting small degrese of in-stent neointima after stent implantation. JACC Cardiovasc Interv. 2008;1:168-173.10.1016/j.jcin.2007.12.00719463295Search in Google Scholar

12. Capodanno D, Prati F, Pawlowsky T, Cera M, La Manna A, Albertucci M, Tamburino C. Comparison of optical coherence tomography and intravascular ultrasound for the assessment of in-stent tissue coverage after stent implantation. EuroIntervention. 2009;5:538-543.10.4244/EIJV5I5A8820142173Search in Google Scholar

13. www.medis.nlSearch in Google Scholar

14. Finn AV, Joner M, Nakazawa G, et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelization. Circulation. 2007;115:2435-2441.10.1161/CIRCULATIONAHA.107.69373917438147Search in Google Scholar

15. Li S, Wang Y, Gai L, et al. Evaluation of neointimal coverage and apposition with various drug-eluting stents over 12 months after implantation by optical coherence tomography. Int J Cardiol. 2011;doi:10.1016/j.ijcard.2011.05.076.10.1016/j.ijcard.2011.05.07621641053Search in Google Scholar

16. Fujii K, Kawasaki D, Oka K, et al. Endothelium-dependent coronary vasomotor response and neointimal coverage of zotarolimus-eluting stents 3 months after implantation.Search in Google Scholar

Heart. 2011;97:977-82.10.1136/hrt.2010.20459421193688Search in Google Scholar

17. Inoue T, Shite J, Yoon J, et al. Optical coherence evaluation of everolimus-eluting stents 8 months after implantation. Heart. 2011;97:1379-1384.10.1136/hrt.2010.20433921051456Search in Google Scholar

18. Guagliumi G, Sirbu V, Musumeci G, et al. Strut coverage and vessel wall response to a new-generation paclitaxeleluting stent with an ultrathin biodegradable abluminal polymer: Optical Coherence Tomography Drug-Eluting Stent Investigation (OCTDESI). Circ Cardiovasc Interv. 2010;3:367-375.10.1161/CIRCINTERVENTIONS.110.95015420647562Search in Google Scholar

19. La Manna A, Capodanno D, Cera M, et al. Optical coherence tomographic results at six-month follow-up evaluation of the CATANIA coronary stent system with nanothin Polyzene-F surface modification (from the Assessment of The LAtest Non-Thrombogenic Angioplasty Stent [ATLANTA] trial). Am J Cardiol. 2009;103:1551-1555.10.1016/j.amjcard.2009.01.37819463514Search in Google Scholar

20. La Manna A, Prati F, Capodanno D, et al. Head-to-head comparison of early vessel healing by optical coherence tomography after implantation of different stents in the same patient. J Cardiovasc Med. 2011;12:328-333.10.2459/JCM.0b013e328340642820962664Search in Google Scholar

21. Kubo T, Imanishi T, Kitabata H., et al. Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: a serial optical coherence tomography study. JACC Cardiovasc Imaging. 2008;1:475-484.10.1016/j.jcmg.2008.03.01219356470Search in Google Scholar

22. Templin C, Meyer M, Muller MF, et al. Coronary optical frequency domain imaging (OFDI) for in vivo evaluation of stent healing: comparison with light and electron microscopy. Eur Heart J. 2010;31:1792-1801.10.1093/eurheartj/ehq168290371520525979Search in Google Scholar

23. Tahara S, Bezerra HG, Sirbu V, et al. Angiographic, IVUS and OCT evaluation of the long-term impact of coronary disease severity at the site of overlapping drug-eluting and bare metal stents: a substudy of the ODESSA trial. Heart. 2010;96:1574-1578.10.1136/hrt.2009.18803720736206Search in Google Scholar

24. Guagliumi G, Musumeci G, Sirbu V, et al. Optical coherence tomography assessment of in vivo vascular response following implantation of overlapping bare-metal and drug-eluting stents. JACC Cardiovasc Interv. 2010;3:531-539.10.1016/j.jcin.2010.02.00820488410Search in Google Scholar

25. Katoh H, Shite J, Shinke T, et al. Delayed neontimalization on sirolimus-eluting stents: 6-month and 12-month follow up by optical coherence tomography. Circ J. 2009;73:1033-1037.10.1253/circj.CJ-08-074619367014Search in Google Scholar

26. Kim JS, Jang IK, Fan C, et al. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial. JACC Cardiovasc Interv. 2009;2:1240-1247.10.1016/j.jcin.2009.10.00620129551Search in Google Scholar

27. Kim JS, Fan C, Choi D, et al. Different patterns of neointimal coverage between acute coronary syndrome and stable angina after various types of drug-eluting stents implantation; 9-month follow-up optical coherence tomography study. Int J Cardiol. 2011;146:341-346.10.1016/j.ijcard.2009.07.01219709765Search in Google Scholar

28. Barlis P, Regar E, Serruys PW, et al. An optical coherence tomography study of a biodegradable vs durable polymercoated limus-eluting stent: a LEADERS trial substudy. Eur Heart J. 2010;31:165-176.10.1093/eurheartj/ehp48019889649Search in Google Scholar

29. Guagliumi G, Sirbu V, Costa MS, et al. Long-term strut coverage of paclitaxel eluting stents compared to bare-metal stents implanted during primary PCI in acute myocardial infarction: HORIZONS-OCT. Circulation. 2011;123:274-281.10.1161/CIRCULATIONAHA.110.96318121220730Search in Google Scholar

30. Guagliumi G, Sirbu V, Bezerra HG, et al. Strut coverage and vessel wall response to zotarolimus-eluting and bare metal stents implanted in patients with ST-elevation myocardial infarction: the OCTAMI study. JACC Cardiovasc Interv. 2010;3:680-687.10.1016/j.jcin.2010.04.00520630463Search in Google Scholar

31. www.clinicaltrials.govSearch in Google Scholar

32. Tahara S, Chamié D, Baibars M, Alraies C, Costa M. Optical coherence tomography endpoints in stent clinical investigations: strut coverage. Int J Cardiovasc Imaging. 2011;27:271-287.10.1007/s10554-011-9796-3445964521394615Search in Google Scholar

33. www.infraredx.comSearch in Google Scholar

34. Dixon SR, Grines CL, Munir A et al. Analysis of target lesion length before coronary artery stenting using angiography and near-infrared spectroscopy versus angiography alone. Am J Cardiol. 2012;109:60-66.10.1016/j.amjcard.2011.07.06821962996Search in Google Scholar

35. Goldstein JA, Maini B, Dixon SR et al. Detection of lipidcore plaques by intracoronary near-infrared spectroscopy identifies high risk of periprocedural myocardial infarction. Circ Cardiovasc Interv. 2011;4:429-437.10.1161/CIRCINTERVENTIONS.111.96326421972399Search in Google Scholar

36. Groves EM, Seto AH, Kern MJ. Invasive Testing for Coronary Artery Disease: FFR, IVUS, OCT, NIRS. Cardiol Clin. 2014;32:405-417.10.1016/j.ccl.2014.04.00525091966Search in Google Scholar

37. Roleder T, Kovacic JC, Ali Z et al. Combined NIRS and IVUS imaging detects vulnerable plaque using a single catheter system: a head-to-head comparison with OCT. EuroIntervention. 2014;10:303-311.10.4244/EIJV10I3A5324769522Search in Google Scholar

38. Brugaletta S, Sabaté M. Assessment of plaque composition by intravascular ultrasound and near-infrared spectroscopy: from PROSPECT I to PROSPECT II. Circ J. 2014;78:1531-1539. 10.1253/circj.CJ-14-0496Search in Google Scholar